Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 1, 2010, Pages 303-309

  Casamassima, Francesco ^a,b   Huang, Jie ^b,c   Fava, Maurizio ^b,c   Sachs, Gary S ^b,c   Smoller, Jordan W ^b,c   Cassano, Giovanni B ^a   Lattanzi, Lorenzo ^a   Fagerness, Jes ^b   Stange, Jonathan P ^b   Perlis, Roy H ^b,c  

^a UNIVERSITY OF PISA   (Italy)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bipolar spectrum; CACNA1C; Suicidality

Indexed keywords

CITALOPRAM; DNA;

ADULT; AGED; AGITATION; ALLELE; ARTICLE; BIPOLAR DISORDER; BIPOLAR LIABILITY GENE; CAUCASIAN; DISEASE SEVERITY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL CONCENTRATION; PHENOTYPE; PRIORITY JOURNAL; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDE;

ALLELES; BIPOLAR DISORDER; CALCIUM CHANNELS, L-TYPE; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 73949093011     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30962     Document Type: Article

References (80)

1. Abrams R, Taylor MA. 1980. A comparison of unipolar and bipolar depressive illness. Am J Psychiatry 137(9):1084-1087.
2. Akiskal HS, Mallya G. 1987. Criteria for the "soft" bipolar spectrum: Treatment implications. Psychopharmacol Bull 23(1):68-73.
3. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. 1977. Cyclothymic disorder: Validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 134(11):1227-1233.
4. Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M. 1983. Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors. J Affect Disord 5(2): 115-128.
5. Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, Warshaw M, Clayton P, Goodwin F. 1995. Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 52(2):114-123.
6. Akiskal HS, Azorin JM, Hantouche EG. 2003. Proposed multidimensional structure of mania: Beyond the euphoric-dysphoric dichotomy. J Affect Disord 73(1-2):7-18.
7. Akiskal HS, Kilzieh N, Maser JD, Clayton PJ, Schettler PJ, Traci Shea M, Endicott J, Scheftner W, Hirschfeld RM, Keller MB. 2006. The distinct temperament profiles of bipolar I, bipolar II and unipolar patients. J Affect Disord 92(1):19-33. Epub 2006 Apr 25.
8. Andreasen NC, Grove WM, Coryell WH, Endicott J, Clayton PJ. 1988. Bipolar versus unipolar and primary versus secondary affective disorder: Which diagnosis takes precedence? J Affect Disord 15(1):69-80.
9. Angst J. 1978. The course of affective disorders. II. Typology of bipolar manic-depressive illness. Arch Psychiatr Nervenkr 226(1):65-73.
10. Angst J. 2007. The bipolar spectrum. Br J Psychiatry 190:189-191.
11. Angst J, Cassano G. 2005. The mood spectrum: Improving the diagnosis of bipolar disorder. Bipolar Disord 7(Suppl4):4-12. Review.
12. Baethge C, Baldessarini RJ, Freudenthal K, Streeruwitz A, Bauer M, Bschor T. 2005. Hallucinations in bipolar disorder: Characteristics and comparison to unipolar depression and schizophrenia. Bipolar Disord 7(2): 136-145.
13. Benazzi F. 2003. Is there a link between atypical and early-onset "unipolar" depression and bipolar II disorder? Compr Psychiatry 44(2):102-109.
14. Benazzi F, Akiskal HS. 2006. Psychometric delineation of the most discriminant symptoms of depressive mixed states. Psychiatry Res 141(1):81-88. Epub 2005 Nov 28.
15. Benazzi F, Rihmer Z. 2000. Sensitivity and specificity of DSM-IV atypical features for bipolar II disorder diagnosis. Psychiatry Res 93(3):257-262.
16. Bremer T, Man A, Kask K, Diamond C. 2006. CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension. Pharmacogenomics 7(3):271-279.
17. Brockington IF, Altman E, Hillier V, Meltzer HY, Nand S. 1982. The clinical picture of bipolar affective disorder in its depressed phase. A report from London and Chicago. Br J Psychiatry 141:558-562.
18. Cassano GB, Dell'Osso L, Frank E, Miniati M, Fagiolini A, Shear K, Pini S, Maser J. 1999. The bipolar spectrum: A clinical reality in search of diagnostic criteria and an assessment methodology. J Affect Disord 54(3):319-328. Review.
19. Cassano GB, Frank E, Miniati M, Rucci P, Fagiolini A, Pini S, Shear MK, Maser JD. 2002. Conceptual underpinnings and empirical support for the mood spectrum. Psychiatr Clin North Am 25(4):699-712 v. Review.
20. Cassano GB, Rucci P, Frank E, Fagiolini A, Dell'Osso L, Shear MK, Kupfer DJ. 2004. The mood spectrum in unipolar and bipolar disorder: Arguments for a unitary approach. Am J Psychiatry 161(7): 1264-1269.
21. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS. 1995. Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 152(3):385-390.
22. Damluji NF, Ferguson JM. 1988. Paradoxical worsening of depressive symptomatology caused by antidepressants. J Clin Psychopharmacol 8(5):347-349.
23. Deckersbach T, Perlis RH, Frankle WG, Gray SM, Grandin L, Dougherty DD, Nierenberg AA, Sachs GS. 2004. Presence of irritability during depressive episodes in bipolar disorder. CNS Spectr 9(3):227-231.
24. Dunner DL, Dwyer T, Fieve RR. 1976. Depressive symptoms in patients with unipolar and bipolar affective disorder. Compr Psychiatry 17(3):447-451.
25. Fagiolini A, Kupfer DJ. 2003. Is treatment-resistant depression a unique subtype of depression? Biol Psychiatry 53(8):640-648. Review.
26. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, Quitkin FM, Wisniewski S, Lavori PW, Rosenbaum JF, Kupfer DJ. 2003. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 26(2): 457-494 x. Review.
27. Fava GA, Tomba E, Grandi S. 2007. The road to recovery from depression-don't drive today with yesterday's map. Psychother Psychosom 76(5): 260-265.
28. Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ, MacLean AW, St CD, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH, Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick EM, McGuffin P, Daly MJ, Corvin AP, HolmansPA, BlackwoodDH,GurlingHM,OwenMJ, Purcell SM, Sklar P, Craddock N, Wellcome Trust Case Control Consortium. 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40(9):1056-1058.
29. Forty L, Smith D, Jones L, Jones I, Caesar S, Cooper C, Fraser C, Gordon-Smith K, Hyde S, Farmer A, McGuffin P, Craddock N. 2008. Clinical differences between bipolar and unipolar depression. Br J Psychiatry 192(5):388-389.
30. Fu Q, Heath AC, Bucholz KK, Nelson EC, Glowinski AL, Goldberg J, Lyons MJ, Tsuang MT, Jacob T, True MR, Eisen SA. 2002. A twin study of genetic and environmental influences on suicidality in men. Psychol Med 32(1):11-24.
31. Gargus JJ. 2006. Ion channel functional candidate genes in multigenic neuropsychiatric disease. Biol Psychiatry 60(2):177-185.
32. Ghaemi N, Sachs GS, Goodwin FK. 2000. What is to be done? Controversies in the diagnosis and treatment of manic-depressive illness. World J Biol Psychiatry 1(2):65-74. Review.
33. Ghaemi SN, Ko JY, Goodwin FK. 2002. "Cade's disease" and beyond: Misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry 47(2):125-134. Review.
34. Goes FS, Sadler B, Toolan J, Zamoiski RD, Mondimore FM, Mackinnon DF, Schweizer B. Bipolar Disorder Phenome Group. Raymond Depaulo J Jr, Potash JB, 2007. Psychotic features in bipolar and unipolar depression. Bipolar Disord 9(8):901-906.
35. Goldberg JF, Harrow M, Whiteside JE. 2001. Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry 158(8):1265-1270.
36. Guze SB, Woodruff RA Jr, Clayton PJ. 1975. The significance of psychotic affective disorders. Arch Gen Psychiatry 32(9):1147-1150.
37. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
38. Hantouche EG, Angst J, Akiskal HS. 2003. Factor structure of hypomania: Interrelationships with cyclothymia and the soft bipolar spectrum. J Affect Disord 73(1-2):39-47.
39. Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, Keck PE Jr, Lewis L, McElroy SL, McNulty JP, Wagner KD. 2003. Screening for bipolar disorder in the community. J Clin Psychiatry 64(1):53-59.
40. Horwitz RI, Singer BH, Makuch RW, Viscoli CM. 1996. Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation. J Clin Epidemiol 49(4):395-400.
41. Jick H, Kaye JA, Jick SS. 2004. Antidepressants and the risk of suicidal behaviors. JAMA 292(3):338-343.
42. Khan A, Khan S, Kolts R, Brown WA. 2003. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports. Am J Psychiatry 160(4):790-792.
43. King RA, Riddle MA, Chappell PB, Hardin MT, Anderson GM, Lombroso P, Scahill L. 1991. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 30(2):179-186.
44. Klerman GL. 1981.The spectrum of mania.ComprPsychiatry 22(1):11-20.
45. Laje G, Paddock S, Manji H, Rush AJ, Wilson AF, Charney D, McMahon FJ. 2007. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry 164(10):1530-1538.
46. MammenOK, Pilkonis PA, Chengappa KN, Kupfer DJ. 2004. Anger attacks in bipolar depression: Predictors and response to citalopram added to mood stabilizers. J Clin Psychiatry 65(5):627-633.
47. Masand P, Gupta S, Dewan M. 1991. Suicidal ideation related to fluoxetine treatment. N Engl J Med 324(6):420.
48. Mitchell PB, Wilhelm K, Parker G, Austin MP, Rutgers P, Malhi GS. 2001. The clinical features of bipolar depression: A comparison with matched major depressive disorder patients. J Clin Psychiatry 62(3):212-216.
49. Mulder RT, Joyce PR, Frampton CM, Luty SE. 2008. Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts. Acta Psychiatr Scand 118(2):116-122.
50. Olfson M, Marcus SC. 2008. A case-control study of antidepressants and attempted suicide during early phase treatment of major depressive episodes. J Clin Psychiatry 69(3):425-432.
51. Olfson M, Das AK, Gameroff MJ, Pilowsky D, Feder A, Gross R, Lantigua R, Shea S, Weissman MM. 2005. Bipolar depression in a low-income primary care clinic. Am J Psychiatry 162(11):2146-2151.
52. Parker G, Roy K, Hadzi-Pavlovic D, Mitchell P, Wilhelm K, Menkes DB, Snowdon J, Loo C, Schweitzer I. 2000. Subtyping depression by clinical features: The Australasian database. Acta Psychiatr Scand 101(1):21-28.
53. Perlis RH, Smoller JW, Fava M, Rosenbaum JF, Nierenberg AA, Sachs GS. 2004. The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder. J Affect Disord 79(1-3):291-295.
54. Perlis RH, Brown E, Baker RW, Nierenberg AA. 2006. Clinical features of bipolar depression versus major depressive disorder in large multicenter trials. Am J Psychiatry 163(2):225-231.
55. Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH,Smoller JW. 2007. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry 64(6):689-697.
56. Perris C. 1966. A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiatr Scand Suppl 194:9-189.
57. Perugi G, Akiskal HS, Ramacciotti S, Nassini S, Toni C, Milanfranchi A, Musetti L. 1999. Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: Is there a bipolar II connection? J Psychiatr Res 33(1):53-61.
58. Purcell S, Cherny SS, Sham PC. 2003. Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1):149-150.
59. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC. 2007. PLINK: A toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 81(3):559-575.
60. Roy-Byrne P, PostRM,UhdeTW,Porcu T, Davis D. 1985. The longitudinal course of recurrent affective illness: Life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl 317:1-34.
61. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. 1996. The Inventory of Depressive Symptomatology (IDS): Psychometric properties. Psychol Med 26(3):477-486.
62. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. 2003. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR):A psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54(5):573-583.
63. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, Thase ME, Nierenberg AA, Quitkin FM, Kashner TM, Kupfer DJ, Rosenbaum JF, Alpert J, Stewart JW, McGrath PJ, Biggs MM, Shores-Wilson K, Lebowitz BD, Ritz L, Niederehe G, STAR*D Investigators Group. 2004. Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design. Control Clin Trials 25(1): 119-142.
64. Sato T, Bottlender R, Schröter A, Möller HJ. 2003. Frequency of manic symptoms during a depressive episode and unipolar 'depressive mixed state' as bipolar spectrum. Acta Psychiatr Scand 107(4):268-274.
65. Serretti A, Mandelli L, Lattuada E, Cusin C, Smeraldi E. 2002. Clinical and demographic features of mood disorder subtypes. Psychiatry Res 112(3):195-210.
66. Sharma V, Khan M, Smith A. 2005. A closer look at treatment resistant depression: Is it due to a bipolar diathesis? J Affect Disord 84(2-3): 251-257.
67. Shi L, Thiebaud P, McCombs JS. 2004. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program. J Affect Disord 82(3):373-383.
68. Simon GE, Savarino J, Operskalski B, Wang PS. 2006. Suicide risk during antidepressant treatment. Am J Psychiatry 163(1):41-47.
69. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM. 2008. Whole-genome association study of bipolar disorder. Mol Psychiatry 13(6):558-569. Epub 2008 Mar 4.
70. Solomon DA, Leon AC, Maser JD, Truman CJ, Coryell W, Endicott J, Teres JJ, Keller MB. 2006. Distinguishing bipolar major depression from unipolar major depression with the screening assessment of depression-polarity (SAD-P). J Clin Psychiatry 67(3):434-442.
71. Statham DJ, Heath AC, Madden PA, Bucholz KK, Bierut L, Dinwiddie SH, Slutske WS, Dunne MP, Martin NG. 1998. Suicidal behaviour: An epidemiological and genetic study. Psychol Med 28(4):839-855.
72. Storosum JG, van Zwieten BJ, van den Brink W, Gersons BP, Broekmans AW.2001. Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 158(8):1271-1275.
73. Strober M, Carlson G. 1982. Bipolar illness in adolescents with major depression: Clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation. Arch Gen Psychiatry 39(5):549-555.
74. Teicher MH, Glod C, Cole JO. 1990. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 147(2): 207-210.
75. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM. 2004. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychol Med 34(1):73-82.
76. US Food and Drug Administration. 2004. FDA public health advisory: Suicidality in children and adolescents being treated with antidepressant medications, Oct 15, 2004. http://www.fda.gov/cder/drug/antidepressants/ SSRIPHA200410.htm.
77. WangY, Zhang J, Li X, Ji J, Yang F,WanC, Feng G,WanP,He L, HeG. 2008. SCN8A as a novel candidate gene associated with bipolar disorder in the Han Chinese population. Prog Neuropsychopharmacol Biol Psychiatry 32(8):1902-1904. Epub 2008 Sep 10.
78. Wasserman D, Geijer T, Rozanov V, Wasserman J. 2005. Suicide attempt and basic mechanisms in neural conduction: Relationships to the SCN8A and VAMP4 genes. Am J Med Genet Part B 133B(1):116-119.
79. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lépine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK. 1996. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276(4):293-299.
80. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA, for the STARD Investigators. 2006. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract 12(2): 71-79.